Who Paid My Doc
John Spence
Undersea and Hyperbaric Medicine Vidalia, GA Medical Doctor
NPI 1124034996 CMS profile 322770
101 Harris Industrial Blvd, Suite E, Vidalia, GA 30474
General payments
$569
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Spence of Vidalia, GA is reported in the CMS Open Payments database as having received $569 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 57th percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $72 | 3 | |
| 2024 | General | $138 | 5 | |
| 2023 | General | $15 | 1 | |
| 2021 | General | $79 | 2 | |
| 2020 | General | $69 | 2 | |
| 2019 | General | $197 | 10 |
Beside peers
- John Spence
- Undersea and Hyperbaric Medicine median
- Middle half of Undersea and Hyperbaric Medicine
- National median
In program year 2025, general payments to John Spence were reported at $72. Among 65 Undersea and Hyperbaric Medicine profiles paid that year, the median was $153 and the middle half received between $68 and $340.
Show as a table
| Year | John Spence | Undersea and Hyperbaric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $197 | $162 | $85–$376 | $163 |
| 2020 | $69 | $111 | $46–$307 | $114 |
| 2021 | $79 | $154 | $50–$306 | $132 |
| 2022 | $0 | $122 | $40–$378 | $149 |
| 2023 | $15 | $145 | $52–$410 | $160 |
| 2024 | $138 | $146 | $80–$316 | $164 |
| 2025 | $72 | $153 | $68–$340 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
342
Drug cost
$3,783
Branded share of claims
13.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Cefdinir | Generic | 82 | $1,184 | |
| Liothyronine Sodium | Generic | 31 | $864 | |
| Doxycycline Monohydrate | Generic | 68 | $695 | |
| Ampicillin Trihydrate | Generic | 24 | $281 | |
| Doxycycline Hyclate | Generic | 25 | $242 | |
| Ciprofloxacin Hcl | Generic | 29 | $134 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 31 | $127 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 14 | $100 | |
| Clindamycin Hcl | Generic | 16 | $86 | |
| Anastrozole | Generic | 11 | $52 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$91,448
Medicare patients
129
Services billed
2,189
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 57% | |
| Diabetes | 50% | |
| Chronic kidney disease | 48% | |
| Ischemic heart disease | 36% | |
| Heart failure | 29% | |
| Depression | 29% | |
| Atrial fibrillation | 28% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Undersea and Hyperbaric Medicine in Georgia
Belinda Marcus
Undersea and Hyperbaric Medicine · Newnan, GA
Dana Conner
Undersea and Hyperbaric Medicine · Blairsville, GA
Jose Gomez
Undersea and Hyperbaric Medicine · Calhoun, GA
John McGlynn
Undersea and Hyperbaric Medicine · Marietta, GA
Mark Leski
Undersea and Hyperbaric Medicine · Athens, GA
Sid Shah
Undersea and Hyperbaric Medicine · Conyers, GA
Related records
Undersea and Hyperbaric Medicine in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Undersea and Hyperbaric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.